Endpoints News
Biopharma industry pushes back on FDA’s ‘America First’ user fee proposals
Biopharma industry representatives are taking issue with some of the FDA’s more political proposals in the next round of user fee agreements, particularly ones that would limit the small business waiver to only US applicants …